Articles:

Jian-Zhong Qin, Lawrence Stennett, Patricia Bacon, Barbara Bodner, Mary J.C. Hendrix, Richard E.B. Seftor, Elisabeth A. Seftor, Naira V. Margaryan, Pamela M. Pollock, Amy Curtis, Jeffrey M. Trent, Frank Bennett, Lucio Miele, and Brian J. Nickoloff

p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas
Mol Cancer Ther 2004 3: 895-902. [Abstract] [Full Text] [PDF]  

Kyoung Jin P. Yoon, Janice L. Hyatt, Christopher L. Morton, Richard E. Lee, Philip M. Potter, and Mary K. Danks

Characterization of inhibitors of specific carboxylesterases: Development of carboxylesterase inhibitors for translational application
Mol Cancer Ther 2004 3: 903-909. [Abstract] [Full Text] [PDF]  

Terry Y-K. Chow, Moulay A. Alaoui-Jamali, Chiaoli Yeh, Leonard Yuen, and David Griller

The DNA double-stranded break repair protein endo-exonuclease as a therapeutic target for cancer
Mol Cancer Ther 2004 3: 911-920. [Abstract] [Full Text] [PDF]  

Daniel E.H. Afar, Vinay Bhaskar, Eric Ibsen, Danna Breinberg, Susan M. Henshall, James G. Kench, Marija Drobnjak, Rick Powers, Melanie Wong, Ferdinand Evangelista, Chris O'Hara, David Powers, Robert B. DuBridge, Ingrid Caras, Ruth Winter, Terri Anderson, Nanette Solvason, Phillip D. Stricker, Carlos Cordon-Cardo, Howard I. Scher, John J. Grygiel, Robert L. Sutherland, Richard Murray, Vanitha Ramakrishnan, and Debbie A. Law

Preclinical validation of anti-TMEFF2-auristatin E–conjugated antibodies in the treatment of prostate cancer
Mol Cancer Ther 2004 3: 921-932. [Abstract] [Full Text] [PDF]  

Vaqar Mustafa Adhami, Moammir Hasan Aziz, Shannon R. Reagan-Shaw, Minakshi Nihal, Hasan Mukhtar, and Nihal Ahmad

Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery
Mol Cancer Ther 2004 3: 933-940. [Abstract] [Full Text] [PDF]  

Jeannie E. Maglione, Erik T. McGoldrick, Lawrence J.T. Young, Ruria Namba, Jeffrey P. Gregg, Lin Liu, Drew Moghanaki, Lesley G. Ellies, Alexander D. Borowsky, Robert D. Cardiff, and Carol L. MacLeod

Polyomavirus middle T–induced mammary intraepithelial neoplasia outgrowths: Single origin, divergent evolution, and multiple outcomes
Mol Cancer Ther 2004 3: 941-953. [Abstract] [Full Text] [PDF]  

Mikael Rinne, David Caldwell, and Mark R. Kelley

Transient adenoviral N-methylpurine DNA glycosylase overexpression imparts chemotherapeutic sensitivity to human breast cancer cells
Mol Cancer Ther 2004 3: 955-967. [Abstract] [Full Text] [PDF]  

Alexander L. Rakhmilevich, Andrea T. Hooper, Daniel J. Hicklin, and Paul M. Sondel

Treatment of experimental breast cancer using interleukin-12 gene therapy combined with anti–vascular endothelial growth factor receptor-2 antibody
Mol Cancer Ther 2004 3: 969-976. [Abstract] [Full Text] [PDF]  

David Raben, Cataldo Bianco, Vincenzo Damiano, Roberto Bianco, Davide Melisi, Chiara Mignogna, Francesco Paolo D'Armiento, Luca Cionini, A. Raffaele Bianco, Giampaolo Tortora, Fortunato Ciardiello, and Paul Bunn

Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model
Mol Cancer Ther 2004 3: 977-983. [Abstract] [Full Text] [PDF]  

Anupama Munshi, John F. Kurland, Takashi Nishikawa, Paul J. Chiao, Michael Andreeff, and Raymond E. Meyn

Inhibition of constitutively activated nuclear factor-B radiosensitizes human melanoma cells
Mol Cancer Ther 2004 3: 985-992. [Abstract] [Full Text] [PDF]  

Cathrine M. Holland, Samir A. Saidi, Amanda L. Evans, Andrew M. Sharkey, John A. Latimer, Robin A.F. Crawford, D. Stephen Charnock-Jones, Cristin G. Print, and Stephen K. Smith

Transcriptome analysis of endometrial cancer identifies peroxisome proliferator-activated receptors as potential therapeutic targets
Mol Cancer Ther 2004 3: 993-1001. [Abstract] [Full Text] [PDF]  

Liang Liu, Joel B. Berletch, Jessica G. Green, Mitchell S. Pate, Lucy G. Andrews, and Trygve O. Tollefsbol

Telomerase inhibition by retinoids precedes cytodifferentiation of leukemia cells and may contribute to terminal differentiation
Mol Cancer Ther 2004 3: 1003-1009. [Abstract] [Full Text] [PDF]  

Joshua P. Klopper, William R. Hays, Vibha Sharma, Margaret A. Baumbusch, Jerome M. Hershman, and Bryan R. Haugen

Retinoid X receptor- and peroxisome proliferator-activated receptor- expression predicts thyroid carcinoma cell response to retinoid and thiazolidinedione treatment
Mol Cancer Ther 2004 3: 1011-1020. [Abstract] [Full Text] [PDF]  

Minireview:

Rochelle Bagatell and Luke Whitesell

Altered Hsp90 function in cancer: A unique therapeutic opportunity
Mol Cancer Ther 2004 3: 1021-1030. [Abstract] [Full Text] [PDF]  

Mark A. Hull, Stanley C.W. Ko, and Gillian Hawcroft

Prostaglandin EP receptors: Targets for treatment and prevention of colorectal cancer?
Mol Cancer Ther 2004 3: 1031-1039. [Abstract] [Full Text] [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.